Literature DB >> 16825951

Gerstmann-Sträussler-Scheinker: a new phenotype with 'curly' PrP deposits.

Monica Colucci1, Francisco J Moleres, Zhi-Liang Xie, Abhik Ray-Chaudhury, Sujata Gutti, Cathrin M Butefisch, Larisa Cervenakova, Wen Wang, Lev G Goldfarb, Qingzhong Kong, Bernardino Ghetti, Shu G Chen, Pierluigi Gambetti.   

Abstract

Gerstmann-Sträussler-Scheinker (GSS) is a hereditary prion disease typically associated with prion protein (PrP)-containing plaques. The protease-resistant, scrapie PrP (PrPSc) is represented by internal fragments, whereas the C-terminal fragments associated with the other prion diseases are generally underrepresented. Different histopathologic and PrPSc features associated with at least 13 PrP gene (PRNP) mutations have been described in GSS. We report the histopathology and PrP characteristics in a father and son carrying a mutation at PRNP codon 187 that substitutes histidine (H) with arginine (R) and is coupled with valine (V) at position 129 (H187R-129V). The PrP plaques were present in both cases but with different structure and topography and minimal spongiform degeneration. A distinctive, "curly" PrP immunostaining was prominent in one case. The protease-resistant PrPSc differed in amount in the 2 cases, possibly depending on whether plaques or the curly immunostain was present. Two protease-resistant PrP fragments of 14 kDa and 7 kDa with, in at least one case, N-terminus between residues 90-99 and 82-90, respectively, codistributed with the plaques, whereas only very small amounts of the PK-resistant PrP were present in the curly staining regions. PK-resistant PrP recovered from the plaque and curly staining regions appeared to be full length.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16825951     DOI: 10.1097/01.jnen.0000228198.81797.4d

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  19 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  Spongiform encephalopathy in transgenic mice expressing a point mutation in the β2-α2 loop of the prion protein.

Authors:  Christina J Sigurdson; Shivanjali Joshi-Barr; Cyrus Bett; Olivia Winson; Giuseppe Manco; Petra Schwarz; Thomas Rülicke; K Peter R Nilsson; Ilan Margalith; Alex Raeber; David Peretz; Simone Hornemann; Kurt Wüthrich; Adriano Aguzzi
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

3.  Squirrel monkeys (Saimiri sciureus) infected with the agent of bovine spongiform encephalopathy develop tau pathology.

Authors:  P Piccardo; J Cervenak; O Yakovleva; L Gregori; K Pomeroy; A Cook; F S Muhammad; T Seuberlich; L Cervenakova; D M Asher
Journal:  J Comp Pathol       Date:  2011-10-20       Impact factor: 1.311

Review 4.  Hereditary Human Prion Diseases: an Update.

Authors:  Matthias Schmitz; Kathrin Dittmar; Franc Llorens; Ellen Gelpi; Isidre Ferrer; Walter J Schulz-Schaeffer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2016-06-20       Impact factor: 5.590

5.  Structural and dynamic properties of the human prion protein.

Authors:  Wei Chen; Marc W van der Kamp; Valerie Daggett
Journal:  Biophys J       Date:  2014-03-04       Impact factor: 4.033

6.  A seven-residue deletion in PrP leads to generation of a spontaneous prion formed from C-terminal C1 fragment of PrP.

Authors:  Carola Munoz-Montesino; Djabir Larkem; Clément Barbereau; Angélique Igel-Egalon; Sandrine Truchet; Eric Jacquet; Naïma Nhiri; Mohammed Moudjou; Christina Sizun; Human Rezaei; Vincent Béringue; Michel Dron
Journal:  J Biol Chem       Date:  2020-08-11       Impact factor: 5.157

7.  De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis.

Authors:  Christina J Sigurdson; K Peter R Nilsson; Simone Hornemann; Mathias Heikenwalder; Giuseppe Manco; Petra Schwarz; David Ott; Thomas Rülicke; Pawel P Liberski; Christian Julius; Jeppe Falsig; Lothar Stitz; Kurt Wüthrich; Adriano Aguzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

Review 8.  The consequences of pathogenic mutations to the human prion protein.

Authors:  Marc W van der Kamp; Valerie Daggett
Journal:  Protein Eng Des Sel       Date:  2009-07-14       Impact factor: 1.650

Review 9.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

10.  Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.

Authors:  Emmanuel A Asante; Ian Gowland; Andrew Grimshaw; Jacqueline M Linehan; Michelle Smidak; Richard Houghton; Olufunmilayo Osiguwa; Andrew Tomlinson; Susan Joiner; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.